IC-MPGN Recruiting Phase 3 Trials for Iptacopan (DB16200)

IndicationStatusPhase
DBCOND0106988 (IC-MPGN)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05755386Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGNTreatment